Chemistry: analytical and immunological testing – Involving immune complex formed in liquid phase – Signal modification or steric inhibition
Patent
1995-05-30
1998-04-21
Ceperley, Mary E.
Chemistry: analytical and immunological testing
Involving immune complex formed in liquid phase
Signal modification or steric inhibition
436546, 436815, 5303889, 5303898, 530807, G01N 33542, G01N 33577, G01N 33533, C07K 1644
Patent
active
057417156
ABSTRACT:
Novel quinidine derivatives are provided which can be used in an improved immunoasssay for the detection of quinidine and quinidine metabolites.
REFERENCES:
patent: 4045420 (1977-08-01), Soffer et al.
patent: 4331808 (1982-05-01), Buckler et al.
patent: 4420568 (1983-12-01), Wang et al.
patent: 4585862 (1986-04-01), Wang et al.
patent: 4668640 (1987-05-01), Wang et al.
patent: 5097097 (1992-03-01), Wang et al.
patent: 5492841 (1996-02-01), Craig
M. Wolff et al., Med. Chem. Res., vol. 1, pp. 101-108 (1991).
A. Soto et al., Clinical Chemistry, vol. 29, No. 6, pp. 1200-1201 (1983).
C. Regan, J. Pharm. Pharmacol., vol. 38, pp. 834-836 (1986).
A. Sidki et al., Cliin. Chem., vol. 33, No. 4, pp. 463-467 (1987).
Mattingly, P.G., Bioconjugate Chemistry, 3:430-431 (1992).
Ghoshal Mitali
Schwenzer Kathryn Sarah
Wu Robert Sundoro
Ceperley Mary E.
Johnston George W.
Rocha-Tramaloni Patricia S.
Roche Diagnostic Systems, Inc.
Semionow Raina
LandOfFree
Quinidine immunoassay and reagents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinidine immunoassay and reagents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinidine immunoassay and reagents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2057120